Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,159,656
-
Share change
-
-943,109
-
Total reported value
-
$25,365,000
-
Put/Call ratio
-
23%
-
Price per share
-
$2.77
-
Number of holders
-
35
-
Value change
-
-$3,919,053
-
Number of buys
-
10
-
Number of sells
-
19
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q4 2021
As of 31 Dec 2021,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,159,656 shares.
The largest 10 holders included
Opaleye Management Inc., Ikarian Capital, LLC, VANGUARD GROUP INC, NEA Management Company, LLC, TWO SIGMA ADVISERS, LP, BlackRock Inc., Linden Advisors LP, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.